TREFOIL THERAPEUTICS
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell-mediated diseases, including Fuchs dystrophy and other serious endothelial cell diseases. The eFGF-1 technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which debilitating and cause a significant amount of preventable blindness throughout the world. Trefoil focuses on a topical eye drop formulation of TTHX1114 for the treatment o... f ulcerative conditions on the front surface of the cornea which leads to corneal scarring and substantial loss of vision. The company's mission is to improve human health and create new therapies using drugs developed with protein engineering. The management team at Trefoil has more than 100 years of pharmaceutical development and commercialization experience. As an early-stage development company, Trefoil has been recognized by the biopharmaceutical funding community through the CONNECT Springboard business plan program award and the Southeast Biotechnology Early Company Competition.
TREFOIL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.trefoiltherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
858.294.0401
Email Addresses:
[email protected]
Total Funding:
85.78 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Tag Manager Apple Mobile Web Clips Icon Google Analytics WordPress Global Site Tag ReCAPTCHA Google Universal Analytics Facebook Sharer
Similar Organizations
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Forge Therapeutics
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Fractyl Health
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Lassogen
Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Trefoil Therapeutics
Solasta Ventures
Solasta Ventures investment in Venture Round - Trefoil Therapeutics
Bios Partners
Bios Partners investment in Series A - Trefoil Therapeutics
Correlation Ventures
Correlation Ventures investment in Series A - Trefoil Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Trefoil Therapeutics
Aju IB Investment
Aju IB Investment investment in Series A - Trefoil Therapeutics
InFocus Capital Partners
InFocus Capital Partners investment in Series A - Trefoil Therapeutics
Access Biotechnology
Access Biotechnology investment in Series A - Trefoil Therapeutics
ExSight Ventures
ExSight Ventures investment in Series A - Trefoil Therapeutics
FemHealth Ventures
FemHealth Ventures investment in Venture Round - Trefoil Therapeutics
Official Site Inspections
http://www.trefoiltherapeutics.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Trefoil Therapeutics"
About Us – Trefoil therapeutics
Dr. McGraw is Chairman and CEO of TheraVida, Inc., a specialty pharmaceutical company, as well as Executive Chairman of Auration Biotech, Inc., a private biotechnology company …See details»
Trefoil Therapeutics - Crunchbase Company Profile
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.See details»
Trefoil Therapeutics - LinkedIn
Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of ...See details»
Trefoil Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Trefoil Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Trefoil Therapeutics , Inc. Management Team | Org Chart
David Eveleth (President, CEO and Founder) | Mark Cpi (Chief Medical Officer) | Thomas Tremblay (Vice President, Clinical Development) | View more for Trefoil Therapeutics , Inc. >>>See details»
Trefoil Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Trefoil Therapeutics Inc of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Trefoil Therapeutics Inc. - VentureRadar
Trefoil Therapeutics was founded by leaders in FGF-1 research and ophthalmic drug development with a commitment to improve the lives of patients with corneal diseases who have few current …See details»
Trefoil Therapeutics Announces the Signing of a License and …
Stewart is an ophthalmologist and founder of PRN, a leading clinical ophthalmic contract research organization, and PharmaFarm which assists startups with unique innovative technology, such …See details»
Trefoil Therapeutics Inc - Buzzfile
Trefoil Therapeutics is located in San Diego, California. This organization primarily operates in the Biotechnical Research, Commercial business / industry within the Engineering, Accounting, …See details»
Trefoil Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Trefoil investors include Bios Partners, Hatteras Venture Partners, Access Biotechnology, Solasta Ventures, InFocus Capital Partners, Correlation Ventures, ExSight Ventures and FemHealth …See details»
Trefoil Therapeutics Company Overview, Contact Details
Mar 22, 2022 Trefoiltherapeutics receives award 'People's Choice at Eyecelerator virtual conference. San Diego, CA - November 12, 2020 - Trefoil Therapeutics, which is developing …See details»
Trefoil Therapeutics - Craft
Trefoil Therapeutics has 5 employees at their 1 location and $33.2 m in total funding,. See insights on Trefoil Therapeutics including office locations, competitors, revenue, financials, …See details»
Trefoil Therapeutics Information - RocketReach
Trefoil Therapeutics is a Pharmaceutical Manufacturing, Manufacturing General, and Health Care company located in San Diego, California with $5 million in revenue and 11 employees. Find …See details»
Trefoil Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Trefoil Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 24, 2023 View Trefoil Therapeutics (www.trefoiltherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Trefoil Therapeutics | San Diego CA - Facebook
Sep 28, 2023 Trefoil Therapeutics, San Diego, California. 26 likes · 1 talking about this. Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sightSee details»
Trefoil Therapeutics, Inc. | Insights
Latest on Trefoil Therapeutics, Inc. Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»
Technology – Trefoil therapeutics
Technology Overview The technology underlying Trefoil’s engineered FGF1, TTHX1114 builds on the well-known activities of naturally-occurring (native) FGF1 to enable its use as a …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»
News – Trefoil therapeutics
May 10, 2023 Trefoil provided an update on the company and its clinical program for TTHX1114 at the inaugural Eyecelerator 2020 virtual conference on November 6. TTHX1114 is the …See details»